Anish Gupta

Array ( [id] => 4274622 [patent_doc_number] => 06323312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Cyclic CRF antagonist peptides' [patent_app_type] => 1 [patent_app_number] => 9/424127 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17687 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323312.pdf [firstpage_image] =>[orig_patent_app_number] => 424127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596982 [patent_doc_number] => 06492490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Liquid phase peptide syntheses of KL-4 pulmonary surfactant' [patent_app_type] => B1 [patent_app_number] => 09/436584 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8089 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492490.pdf [firstpage_image] =>[orig_patent_app_number] => 09436584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417310 [patent_doc_number] => 06518238 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3' [patent_app_type] => B1 [patent_app_number] => 09/418861 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10469 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518238.pdf [firstpage_image] =>[orig_patent_app_number] => 09418861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1587441 [patent_doc_number] => 06482401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Composition for the relief of joint pain and myofascial pain and method of preparing same' [patent_app_type] => B1 [patent_app_number] => 09/410868 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1410 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482401.pdf [firstpage_image] =>[orig_patent_app_number] => 09410868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014806 [patent_doc_number] => 06894150 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin' [patent_app_type] => utility [patent_app_number] => 09/411006 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9621 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894150.pdf [firstpage_image] =>[orig_patent_app_number] => 09411006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311556 [patent_doc_number] => 06610497 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/407427 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 63261 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610497.pdf [firstpage_image] =>[orig_patent_app_number] => 09407427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404686 [patent_doc_number] => 07288516 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-30 [patent_title] => 'Null IGF for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 09/399120 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4190 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288516.pdf [firstpage_image] =>[orig_patent_app_number] => 09399120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439827 [patent_doc_number] => 06495338 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Drug screening and diagnosis based on paracrine tubular renin-angiotensin system' [patent_app_type] => B1 [patent_app_number] => 09/389242 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 30 [patent_no_of_words] => 10027 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495338.pdf [firstpage_image] =>[orig_patent_app_number] => 09389242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272478 [patent_doc_number] => 06323181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Antitumor agents' [patent_app_type] => 1 [patent_app_number] => 9/386555 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13694 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323181.pdf [firstpage_image] =>[orig_patent_app_number] => 386555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404383 [patent_doc_number] => 06528093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Sustained-release preparation' [patent_app_type] => B1 [patent_app_number] => 09/386232 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15499 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528093.pdf [firstpage_image] =>[orig_patent_app_number] => 09386232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417327 [patent_doc_number] => 06514759 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Plant growth factor' [patent_app_type] => B1 [patent_app_number] => 09/373995 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 6200 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514759.pdf [firstpage_image] =>[orig_patent_app_number] => 09373995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699655 [patent_doc_number] => 07067619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Integrin-binding peptides' [patent_app_type] => utility [patent_app_number] => 09/364597 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13620 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067619.pdf [firstpage_image] =>[orig_patent_app_number] => 09364597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370285 [patent_doc_number] => 06288027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Preserving a hemoglobin blood substitute with a transparent overwrap' [patent_app_type] => 1 [patent_app_number] => 9/348881 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19053 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288027.pdf [firstpage_image] =>[orig_patent_app_number] => 348881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1314557 [patent_doc_number] => 06610832 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Preserving a hemoglobin blood substitute with a transparent overwrap' [patent_app_type] => B1 [patent_app_number] => 09/349290 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19160 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610832.pdf [firstpage_image] =>[orig_patent_app_number] => 09349290 [rel_patent_id] =>[rel_patent_doc_number] =>)